Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Quick Stats
Feb 03, 202655.9
AI Score
HOLD0.21
Volume Ratio
Mar 24, 2026
Next Earnings
15
+ve Days (30d)
13
-ve Days (30d)
KZR Stock Summary
Last updated Feb 03, 2026
KZR is currently trading at $6.17, positioned above its 200-day moving average of $4.94, indicating a long-term uptrend. The stock has a 52-week range of $3.5334 to $6.62.
Technical Analysis: The 50-day moving average stands at $6.24, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.042, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.113, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates KZR at 55.9/100 with a HOLD recommendation.
KZR (Kezar Life Sciences, Inc. Common Stock) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.042 |
| CMF (20) | 0.113 |
| ROC (10) | 0.325 |
| ADX (14) | 14.342 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.033 |
| AROONOSC (14) | -21.429 |
| WILLAMS %R (14) | -55.556 |
| MFI (14) | 50.625 |
KZR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KZR Price vs Max Options Open Interest
KZR Max Change In Options Open Interest
KZR Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KZR Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KZR Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KZR Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Kezar Life Sciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
KZR Moving Averages Analysis
Kezar Life Sciences, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 03, 2026
KZR (Kezar Life Sciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 6.17 |
| 20 | 6.2 |
| 30 | 6.24 |
| 50 | 6.24 |
| 100 | 5.63 |
| 200 | 4.94 |
KZR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 44.5 million |
| Earnings/Share ($) | -8.44 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -6.705 |
| EPS Estimate Next Year ($) | -3.27 |
| WallStreet Target Price ($) | 6 |
| Most Recent Quarter |